Maintenance of homeostasis in the aging hypothalamus: The central and peripheral roles of succinate

Frontiers in Endocrinology

Volumn 6, Issue FEB, 2015, Pages

  Chen, Thomas T ^a   Maevsky, Eugene I ^a   Uchitel, Mikhail L ^a  

^a INSTITUTE OF THEORETICAL AND EXPERIMENTAL BIOPHYSICS   (Russian Federation)

Author keywords

Homeostasis; Hypothalamus; Hypoxia inducible factor 1 ; IKK NF B; Menopause; Mitochondria; MTOR; Succinate

Indexed keywords

ADENOSINE TRIPHOSPHATE; BETA ENDORPHIN; CORTICOTROPIN; CYCLIC AMP; ESTROGEN; FOLLITROPIN; GONADORELIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERMEDIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; REACTIVE OXYGEN METABOLITE; SUCCINATE DEHYDROGENASE; SUCCINATE RECEPTOR 1; SUCCINIC ACID; SUCCINIC ACID DERIVATIVE; TESTOSTERONE; UNCLASSIFIED DRUG;

CELL AGING; CELL SURVIVAL; ENZYME ACTIVITY; FEEDBACK SYSTEM; FOOD INTAKE; GENE EXPRESSION; HOMEOSTASIS AND REGULATION; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MENOPAUSE; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 84926643087     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2015.00007     Document Type: Review

References (142)

1. De Luca d'Alessandro E, Bonacci S, Giraldi G. Aging populations: the health and quality of life of the elderly. Clin Ter (2011) 162(1):e13-8.
2. Maffucci JA, Gore A. Hypothalamic neural systems controlling the female reproductive life cycle gonadotropin-releasing hormone, glutamate, and GABA. Int Rev Cell Mol Biol (2009) 274:69-127. doi: 10.1016/S1937-6448(08)02002-9
3. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell (2013) 153:1194-217. doi:10.1016/j.cell.2013.05.039
4. Burch JB, Augustine AD, Frieden LA, Hadley E, Howcroft TK, Johnson R, et al. Advances in geroscience: impact on healthspan and chronic disease. J Gerontol A Biol Sci Med Sci (2014) 69(Suppl 1):S1-3. doi:10.1093/gerona/glu041
5. Utian WH. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Health Qual Life Outcomes (2005) 5(3):47. doi:10.1186/1477-7525-3-47
6. Melmed S, Polonsky KS, Larsen PR, Kronenberg HM. Williams Textbook of Endocrinology. 12th ed. Philadelphia, PA: Saunders Elsevier (2013).
7. Lim CT, Grossman A, Khoo B. Normal physiology of ACTH and GH release in the hypothalamus and anterior pituitary in man. In: Grossman A, editor. Pituitary Disease and Neuroendocrinology. South Dartmouth, MA: MDText.com, Inc. Available from: http://www.endotext.org/section/neuroendo/
8. Hayflick L. The cell biology of aging. Clin Geriatr Med (1985) 1:15-27.
9. Hayflick L. How and Why We Age. New York, NY: Ballantine Books (1994).
10. Martin GM. The biology of aging: 1985-2010 and beyond. FASEB J (2011) 25(11):3756-62. doi:10.1096/fj.11-1102.ufm
11. Dean W. Comprehensive review of the neuroendocrine theory of aging: Chapter 1. Select Proceedings of the 2nd Annual Monaco Anti-Aging Conference. Monaco. Available from: http://warddeanmd.com/articles/neuroendocrine-theory-of-aging-chapter-1/
12. Blagosklonny MV. Answering the ultimate question "what is the proximal cause of aging?". Aging (Albany NY) (2012) 4:861-77.
13. Berman AE, Leontieva OV, Natarajan V, McCubrey JA, Demidenko ZN, Nikiforov MA. Recent progress in genetics of aging, senescence and longevity: focusing on cancer-related genes. Oncotarget (2012) 3:1522-32.
14. Nicolson GL. Mitochondrial dysfunction and chronic disease: treatment with natural supplements. Altern Ther Health Med (2014) 20(Suppl 1):18-25.
15. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains.". Exp Cell Res (1961) 25:585-621. doi:10.1016/0014-4827(61)90192-6
16. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature (1990) 345:458-60. doi:10.1038/345458a0
17. Thorner MO. Endocrinology of aging: the convergence of reductionist science with systems biology and integrative medicine. Front Endocrinol (2010) 1:2. doi:10.3389/fendo.2010.00002
18. Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, et al. Geroscience: linking aging to chronic disease. Cell (2014) 6(159):709-13. doi:10.1016/j.cell.2014.10.039
19. Newgard CB, Pessin JE. Recent progress in metabolic signaling pathways regulating aging and life span. J Gerontol A Biol Sci Med Sci (2014) 69(Suppl 1):S21-7. doi:10.1093/gerona/glu058
20. Dilman VM. Age-associated elevation of hypothalamic, threshold to feedback control, and its role in development, ageing, and disease. Lancet (1971) 1:1211-9. doi:10.1016/S0140-6736(71)91721-1
21. Dilman VM, Anisimov VN. Hypothalamic mechanisms of ageing and of specific age pathology-I. Sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in the reproductive system. Exp Gerontol (1979) 14(4):161-74. doi:10.1016/0531-5565(79)90015-9
22. Hill S, Van Remmen H. Mitochondrial stress signaling in longevity: a new role for mitochondrial function in aging. Redox Biol (2014) 2:936-44. doi:10.1016/j.redox.2014.07.005
23. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci (2014) 69(Suppl 1):S4-9. doi:10.1093/gerona/glu057
24. Anisimov VN. Metformin and rapamycin are master-keys for understanding the relationship between cell senescent, aging and cancer. Aging (Albany NY) (2013) 5:337-8.
25. Larsen PR, Kronenberg HR, Melmed S, Polonsky KS. Williams Textbook of Endocrinology. 10th ed. St. Louis, MO: Larsen Saunders/Elsevier (2003).
26. Brann DW, Mahesh VB. The aging reproductive neuroendocrine axis. Steroids (2005) 70:273-83. doi:10.1016/j.steroids.2004.12.008
27. Neal-Perry G, Nejat E, Dicken C. The neuroendocrine physiology of female reproductive aging: an update. Maturitas (2010) 67:34-8. doi:10.1016/j.maturitas.2010.04.016
28. Wise PM, Kashon ML, Krajnak KM, Rosewell KL, Cai A, Scarbrough K, et al. Aging of the female reproductive system: a window into brain aging. Recent Prog Horm Res (1997) 52:279-303.
29. Wise PM, Smith MJ, Dubal DB, Wilson ME, Rau SW, Cashion AB, et al. Neuroendocrine modulation and repercussions of female reproductive aging. Recent Prog Horm Res (2002) 57:235-56. doi:10.1210/rp.57.1.235
30. Downs JL, Wise PM. The role of the brain in female reproductive aging. Mol Cell Endocrinol (2009) 299:32-8. doi:10.1016/j.mce.2008.11.012
31. Morrison JH, Brinton RD, Schmidt PJ, Gore AC. Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women. J Neurosci (2006) 26:10332-48. doi:10.1523/JNEUROSCI.3369-06.2006
32. Yin W, Gore AC. Neuroendocrine control of reproductive aging: roles of GnRH neurons. Reproduction (2006) 131:403-14. doi:10.1530/rep.1.00617
33. Lovejoy JC. Weight gain in women at midlife: the influence of menopause. Obes Manag (2009) 5(2):52-6. doi:10.1089/obe.2009.0203
34. Roa J, Herbison AE. Direct regulation of GnRH neuron excitability by arcuate nucleus POMC and NPY neuron neuropeptides in female mice. Endocrinology (2012) 153(11):5587-99. doi:10.1210/en.2012-1470
35. Wellhauser L, Gojska NM, Belsham DD. Delineating the regulation of energy homeostasis using hypothalamic cell models. Front Neuroendocrinol (2014). doi:10.1016/j.yfrne.2014.09.001
36. Zink AN, Perez-Leighton CE, Kotz CM. The orexin neuropeptide system: physical activity and hypothalamic function throughout the aging process. Front Syst Neurosci (2014) 8:211. doi:10.3389/fnsys.2014.00211
37. Tang Y, Cai D. Hypothalamic inflammation and GnRH in aging development. Cell Cycle (2013) 12(17):2711-2. doi:10.4161/cc.26054
38. Yonker JA, Chang V, Roetker NS, Hauser TS, Hauser RM, Atwood CS. Hypothalamic-pituitary-gonadal axis homeostasis predicts longevity. Age (Dordr) (2013) 1:129-38. doi:10.1007/s11357-011-9342-1
39. Dilman VM, Bobrov JF, Ostroumova MN, Lvovich EG, Vishnevsky AS, Anisimov VN, et al. Hypothalamic mechanisms of ageing and of specific age pathology-III. Sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in energy systems. Exp Gerontol (1979) 14(5):217-24. doi:10.1016/0531-5565(79)90015-9
40. Dilman VM, Ostroumova MN, Tsyrlina EV. Hypothalamic mechanisms of ageing and of specific age pathology-II. On the sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in adaptive homestasis. Exp Gerontol (1979) 14(4):175-81. doi:10.1016/0531-5565(79)90015-9
41. Martínez de la Escalera G, Choi AL, Weiner RI. Signaling pathways involved in GnRH secretion in GT1 cells. Neuroendocrinology (1995) 61:310-7. doi:10.1159/000126853
42. Dilman VM. Hypothalamic mechanisms of ageing and of specific age pathology-V. A model for the mechanism of human specific age pathology and natural death. Exp Gerontol (1979) 14(6):287-300. doi:10.1016/0531-5565(79)90040-8
43. Weiss G, Skurnick JH, Goldsmith LT, Santoro NF, Park SJ. Menopause and hypothalamic-pituitary sensitivity to estrogen. JAMA (2004) 292:2991-6. doi:10.1001/jama.292.24.2991
44. Guo S. Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J Endocrinol (2014) 220:T1-23. doi:10.1530/JOE-13-0327
45. De Tata V. Age-related impairment of pancreatic beta-cell function: pathophysiological and cellular mechanisms. Front Endocrinol (2014) 5:138. doi:10.3389/fendo.2014.00138
46. Rapacciuolo A, Suvarna S, Barki-Harrington L, Luttrell LM, Cong M, Lefkowitz RJ, et al. Protein kinase A and G protein-coupled receptor kinase phosphorylation mediates beta-1adrenergic receptor endocytosis through different pathways. J Biol Chem (2003) 278:35403-11. doi:10.1074/jbc.M305675200
47. Ferrara N, Komici K, Corbi G, Pagano G, Furgi G, Rengo C, et al. β-adrenergic receptor responsiveness in aging heart and clinical implications. Front Physiol (2014) 4:396. doi:10.3389/fphys.2013.00396
48. Grammatopoulos DK. Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction. Br J Pharmacol (2012) 166:85-97. doi:10.1111/j.1476-5381.2011.01631.x
49. Griesinger G, Felberbaum R, Diedrich K. GnRH-antagonists in reproductive medicine. Arch Gynecol Obstet (2005) 273:71-8. doi:10.1007/s00404-005-0021-2
50. Frank SJ. Growth hormone signalling and its regulation: preventing too much of a good thing. Growth Horm IGF Res (2001) 11:201-12. doi:10.1054/ghir.2001.0237
51. Conti M, Harwood JP, Dufau ML, Catt KJ. Effect of gonadotropin-induced receptor regulation on biological responses of isolated rat luteal cells. J Biol Chem (1977) 252:8869-74.
52. Ye J. Mechanisms of insulin resistance in obesity. Front Med (2013) 7(1):14-24. doi:10.1007/s11684-013-0262-6
53. Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG. Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci (2004) 27:107-44. doi:10.1146/annurev.neuro.27.070203.144206
54. Grady EF, Böhm SK, Bunnett NW. Turning off the signal: mechanisms that attenuate signaling by G protein-coupled receptors. Am J Physiol (1997) 273(3 Pt 1):G586-601.
55. Ferguson SS. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev (2001) 53:1-24.
56. Shankaran H, Wiley HS, Resat H. Receptor downregulation and desensitization enhance the information processing ability of signalling receptors. BMC Syst Biol (2007) 1:48. doi:10.1186/1752-0509-1-48
57. Epel ES, Lithgow GJ. Stress biology and aging mechanisms: toward understanding the deep connection between adaptation to stress and longevity. J Gerontol A Biol Sci Med Sci (2014) 69(Suppl 1):S10-6. doi:10.1093/gerona/glu055
58. Liang W, Curran PK, Hoang Q, Moreland RT, Fishman PH. Differences in endosomal targeting of human (beta)1-and (beta)2-adrenergic receptors following clathrin-mediated endocytosis. J Cell Sci (2004) 117:723-34. doi:10.1242/jcs.00878
59. Guarente L. Calorie restriction and sirtuins revisited. Genes Dev (2013) 27:2072-85. doi:10.1101/gad.227439.113
60. Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature (2009) 460(7255):587-91. doi:10.1038/nature08197
61. Adams J. Genetic control of aging and life span. Nat Educ (2008) 1(1):130.
62. Adler AS, Sinha D, Kawahara TL, Zhang JY, Segal E, Change HY. Motif module map reveals enforcement of aging by continual NF-kappaB activity. Genes Dev (2007) 21:3244-57. doi:10.1101/gad.1588507
63. Johnson SC, Rabinovitch PS, Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature (2003) 493(7432):338-45. doi:10.1038/nature11861
64. Gabuzda D, Yankner BA. Physiology: inflammation links ageing to the brain. Nature (2013) 497(7448):197-8. doi:10.1038/nature12100
65. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell (2012) 149:274-93. doi:10.1016/j.cell.2012.03.017
66. Howcroft TK, Campisi J, Louis GB, Smith MT, Wise B, Wyss-Coray T, et al. The role of inflammation in age-related disease. Aging (Albany NY) (2013) 5(1):84-93.
67. Kunz J, Henriquez R, Schneider U, Deuter-Reinhard M, Movva NR, Hall MN. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell (1993) 73:585-96. doi:10.1016/0092-8674(93)90144-F
68. Cafferkey R, Young PR, McLaughlin MM, Bergsma DJ, Koltin Y, Sathe GM, et al. Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Mol Cell Biol (1993) 13(10):6012-23.
69. Lamming DW, Ye L, Katajisto P, Goncalves MD, Saitoh M, Stevens DM, et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science (2012) 335:1638-43. doi:10.1126/science.1215135
70. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature (2009) 460(7253):392-5. doi:10.1038/nature08221
71. Gallinetti J, Harputlugil E, Mitchell JR. Amino acid sensing in dietary-restriction-mediated longevity: roles of signal-transducing kinases GCN2 and TOR. Biochem J (2013) 449:1-10. doi:10.1042/BJ20121098
72. Wander SA, Hennessy BT, Slingerland JM. Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy. J Clin Invest (2011) 121(4):1231-41. doi:10.1172/JCI44145
73. Martínez de Morentin PB, Martinez-Sanchez N, Roa J, Ferno J, Nogueiras R, Tena-Sempere M, et al. Hypothalamic mTOR: the rookie energy sensor. Curr Mol Med (2014) 14(1):3-21.
74. Cota D, Proulx K, Smith KA, Kozma SC, Thomas G, Woods SC, et al. Hypothalamic mTOR signaling regulates food intake. Science (2006) 312:927-30. doi:10.1126/science.1124147
75. Cota D. mTORC2, the "other" mTOR, is a new player in energy balance regulation. Mol Metab (2014) 3(4):349-50. doi:10.1016/j.molmet.2014.04.002
76. Zhang H, Zhang G, Gonzalez FJ, Park SM, Cai D. Hypoxia-inducible factor directs POMC gene to mediate hypothalamic glucose sensing and energy balance regulation. PLoS Biol (2011) 9(7):e1001112. doi:10.1371/journal.pbio.1001112
77. Purkayastha S, Zhang G, Cai D. Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-β and NF-κB. Nat Med (2011) 17:883-7. doi:10.1038/nm.2372
78. Cai D, Liu T. Inflammatory cause of metabolic syndrome via brain stress and NF-κB. Aging (Albany NY) (2012) 4(2):98-115.
79. Zhang G, Li J, Purkayastha S, Tang Y, Zhang H, Yin Y, et al. Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH. Nature (2013) 497(7448):211-6. doi:10.1038/nature12143
80. Dan HC, Cooper MJ, Cogswell PC, Duncan JA, Ting JP, Baldwin AS. Akt-dependent regulation of NF-κ B is controlled by mTOR and Raptor in association with IKK. Genes Dev (2008) 22:1490-500. doi:10.1101/gad.1662308
81. Kolovou G, Kolovou V, Vasiliadis I, Giannakopoulou V, Mihas C, Bilianou H, et al. The frequency of 4 common gene polymorphisms in nonagenarians, centenarians, and average life span individuals. Angiology (2014) 65:210-5. doi:10.1177/0003319712475075
82. Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1a. Nature (2013) 496(7444):238-42. doi:10.1038/nature11986
83. Schwartz MW, Porte D Jr. Diabetes, obesity, and the brain. Science (2005) 307(5708):375-9. doi:10.1126/science.1104344
84. Ahima RS, Flier JS. Leptin. Annu Rev Physiol (2000) 62:413-37. doi:10.1146/annurev.physiol.62.1.413
85. Coll AP, Farooqi IS, O'Rahilly S. The hormonal control of food intake. Cell (2007) 129(2):251-62. doi:10.1016/j.cell.2007.04.001
86. Lectez B, Jeandel L, El-Yamani FZ, Arthaud S, Alexandre D, Mardargent A, et al. The orexigenic activity of the hypothalamic neuropeptide 26RFa is mediated by the neuropeptide Y and proopiomelanocortin neurons of the arcuate nucleus. Endocrinology (2009) 150(5):2342-50. doi:10.1210/en.2008-1432
87. Lam TK. Neuronal regulation of homeostasis by nutrient sensing. Nat Med (2010) 16(4):392-5. doi:10.1038/nm0410-392
88. Lam TK, Pocai A, Gutierrez-Juarez R, Obici S, Bryan J, Aguilar-Bryan L, et al. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat Med (2005) 11(3):320-7. doi:10.1038/nm1201
89. Cai Z, Luo W, Zhan H, Semenza GL. Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart. Proc Natl Acad Sci U S A (2013) 110(43):17462-7. doi:10.1073/pnas.1317158110
90. Bernhardt WM, Wiesener MS, Scigalla P, Chou J, Schmieder RE, Günzler V, et al. Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD. J Am Soc Nephrol (2010) 21(12):2151-6. doi:10.1681/ASN.2010010116
91. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, et al. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med (2002) 8(7):702-10. doi:10.1038/nm1102-1329b
92. Peng J, Zhang L, Drysdale L, Fong GH. The transcription factor EPAS-1/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling. Proc Natl Acad Sci U S A (2000) 97(15):8386-91. doi:10.1073/pnas.140087397
93. Parton LE, Ye CP, Coppari R, Enriori PJ, Choi B, Zhang CY, et al. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature (2007) 449:228-32. doi:10.1038/nature06098
94. Ibrahim N, Bosch MA, Smart JL, Qiu J, Rubinstein M, Rønnekleiv OK, et al. Hypothalamic proopiomelanocortin neurons are glucose responsive and express K(ATP) channels. Endocrinology (2003) 144:1331-40. doi:10.1210/en.2002-221033
95. Fedotcheva NI, Sokolov AP, Kondrashova MN. Non-enzymatic formation of succinate under oxidative stress. Free Radic Biol Med (2006) 41(1):56-64. doi:10.1016/j.freeradbiomed.2006.02.012
96. Berg JM, Tymoczko JL, Stryer L. Biochemistry. 5th ed. New York, NY: W H Freeman (2002).
97. Millington GW. The role of proopiomelanocortin (POMC) neurones in feeding behaviour. Nutr Metab (Lond) (2007) 4:18-34. doi:10.1186/1743-7075-4-18
98. Peskov AB, Maevskii EI, Uchitel ML. Composition of energy metabolism substrates increases the efficiency of pharmacotherapy of cardiovascular diseases. Bull Exp Biol Med (2005) 139(6):668-70. doi:10.1007/s10517-005-0373-4
99. Peskov AB, Maevskii EI, Uchitel' ML, Sakharova NY, Vize-Khripunova MA. Succinate-based preparation alleviates manifestations of the climacteric syndrome in women. Bull Exp Biol Med (2005) 140(3):312-4. doi:10.1007/s10517-005-0476-y
100. Kondrashova MN, Grigorenko EV, Khizhnyak EP. Heat production in mitochondria during oxidation of different substrates. Biophysics (1988) 33(3):527-8.
101. Krebs HA. The history of the tricarboxylic acid cycle. Perspect Biol Med (1970) 14:154-70.
102. Kondrashova MN. Structural-kinetics organization of tricarboxylic acid cycle under active functioning of tissues. Biophysics (1989) 34:450-8.
103. Kondrashova MN, Gogvadze VG, Medvedev BI, Babsky AM. Succinic acid oxidation as the only energy support of intensive Ca2+ uptake by mitochondria. Biochem Biophys Res Commun (1982) 109(2):376-81. doi:10.1016/0006-291X(82)91731-4
104. Kondrashova MN, Volkova SP, Kuznetzov IV, Grigorenko EV, Babsky AM, Podoletz A, et al. Rate control of the tricarboxylic acid cycle. Adv Enzyme Regul (1970) 8:335-53. doi:10.1016/0065-2571(70)90028-2
105. Ariza AC, Deen PM, Robben JH. The succinate receptor as a novel therapeutic target for oxidative and metabolic stress-related conditions. Front Endocrinol (Lausanne) (2012) 6(3):22. doi:10.3389/fendo.2012.00022
106. Wen H, Ting JP. Agitation by suffocation: how hypoxia activates innate immunity via the Warburg effect. Cell Metab (2013) 17(6):814-5. doi:10.1016/j.cmet.2013.05.016
107. Virtue S, Vidal-Puig A. Nothing iffy about HIF in the hypothalamus. PLoS Biol (2011) 7:e1001116. doi:10.1371/journal.pbio.1001116
108. Münzberg H, Myers MG Jr. Molecular and anatomical determinants of central leptin resistance. Nat Neurosci (2005) 8(5):566-70. doi:10.1038/nn1454
109. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature (2006) 443:289-95. doi:10.1038/nature05026
110. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature (2000) 404(6778):661-71. doi:10.1038/35007534
111. Maevsky EI, Peskov AB, Uchitel ML, Pogorelov A, Kondrashova MN. Non-hormonal Dietary Supplement that Helps to Manage Symptoms of Menopause. St. Petersburg: GASTRO (2007).
112. Kondrashova MN. The two Krebs cycle intermediates succinate and a-ketoglutarate: from substrates to signal molecules. Chairman's Introduction on the Session: Therapeutic Aspects in Bioenergetics, 14th European Bioenergetics Conference. Moscow: (2006).
113. Maevsky EI, Rosenfield AS, Grishina EV, Kondrashova MN. Correction of Metabolic Acidosis Through Sustaining of Mitochondrial Function. Moscow: ONTI Pushchino (2001).
114. He W, Miao FJ, Lin DC, Schwandner RT, Wang Z, Gao J, et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature (2004) 429:188-93. doi:10.1038/nature02488
115. Deen PM, Robben JH. Succinate receptors in the kidney. J Am Soc Nephrol (2011) 22(8):1416-22. doi:10.1681/ASN.2010050481
116. Edwards CB, Copes N, Brito AG, Canfield J, Bradshaw PC. Malate and fumarate extend lifespan in Caenorhabditis elegans. PLoS One (2013) 8(3):e58345. doi:10.1371/journal.pone.0058345
117. Chouchani ET, Pell VR, Gaude E, Aksentijevic D, Sundier SY, Robb EL, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature (2014) 515:431-5. doi:10.1038/nature13909
118. Maevsky EI, Rosenfeld AS, Peskov AB, Kondrashova MN. Signal, sympathetic action of succinate in experimental and clinical studies. Biochemical and Biophysical Research Communications, Supplemental Volume 14, 14th EBEC Short Reports, Moscow (2006). p. 536-7.
119. Kondrashova MN, Volkova SP, Kuznetzov IV, Grigorenko EV, Babsky AM, Podoletz A, et al. Succinic acid as a physiological signal molecule. In: Winlow W, Vinogradova OS, Sakharov DA, editors. Signal Molecule and Behavior. Manchester, NY: Manchester University Press (1991). p. 295-300.
120. Maevsky EI, Guzar IB, Rosenfeld AS, Kondrashova MN. Does Succinic Acid Mediate adrenalin Stimulation in Mitochondria? EBEC Reports. Lyon: LBTM-CNRS (1982).
121. Regard JB, Sato IT. Coughlin SR. Anatomical profiling of G protein-coupled receptor expression. Cell (2008) 135(3):561-71. doi:10.1016/j.cell.2008.08.040
122. Aguiar CJ, Andrade VL, Gomes ER, Alves MN, Ladeira MS, Pinheiro AC, et al. Succinate modulates Ca(2+) transient and cardiomyocyte viability through PKA-dependent pathway. Cell Calcium (2010) 47(1):37-46. doi:10.1016/j.ceca.2009.11.003
123. Davenport AP, Harmar AJ. Evolving pharmacology of orphan GPCRs: IUPHAR commentary. Br J Pharmacol (2013) 170(4):693-5. doi:10.1111/bph.12339
124. Davenport AP, Alexander SP, Sharman JL, Pawson AJ, Benson HE, Monaghan AE, et al. International union of basic and clinical pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands. Pharmacol Rev (2013) 65(3):967-86. doi:10.1124/pr.112.007179
125. Alexander SP, Mathie A, Peters JA. Guide to receptors and channels (GRAC), 5th edition. Br J Pharmacol (2011) 164(Suppl 1):S1-324. doi:10.1111/j.1476-5381.2011.01649_1.x
126. Toma I, Kang JJ, Sipos A, Vargas S, Bansal E, Hanner F, et al. Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J Clin Invest (2008) 118(7):2526-34. doi:10.1172/JCI33293
127. Robben JH, Fenton RA, Vargas SL, Schweer H, Peti-Peterdi J, Deen PM, et al. Localization of the succinate receptor in the distal nephron and its signaling in polarized MDCK cells. Kidney Int (2009) 76(12):1258-67. doi:10.1038/ki.2009.360
128. Vargas SL, Toma I, Kang JJ, Meer EJ, Peti-Peterdi J. Activation of the succinate receptor GPR91 in macula densa cells causes renin release. J Am Soc Nephrol (2009) 20(5):1002-11. doi:10.1681/ASN.2008070740
129. Macaulay IC, Tijssen MR, Thijssen-Timmer DC, Gusnanto A, Steward M, Burns P, et al. Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins. Blood (2007) 109:3260-9. doi:10.1182/blood-2006-07-036269
130. Hakak Y, Lehmann-Bruinsma K, Phillips S, Le T, Liaw C, Connolly DT, et al. The role of the GPR91 ligand succinate in hematopoiesis. J Leukoc Biol (2009) 85:837-43. doi:10.1189/jlb.1008618
131. Rubic T, Lametschwandtner G, Jost S, Hinteregger S, Kund J, Carballido-Perrig N, et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat Immunol (2008) 9:1261-9. doi:10.1038/ni.1657
132. Kohout TA, Lefkowitz RJ. Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization. Mol Pharmacol (2003) 63:9-18. doi:10.1124/mol.63.1.9
133. Peti-Peterdi J. High glucose and renin release: the role of succinate and GPR91. Kidney Int (2010) 78(12):1214-7. doi:10.1038/ki.2010.333
134. Peti-Peterdi J, Kang JJ, Toma I. Activation of the renal renin-angiotensin system in diabetes-new concepts. Nephrol Dial Transplant (2008) 23:3047-9. doi:10.1093/ndt/gfn377
135. Sadagopan N, Li W, Roberds SL, Major T, Preston GM, Yu Y, et al. Circulating succinate is elevated in rodent models of hypertension and metabolic disease. Am J Hypertens (2007) 20:1209-15.
136. Weinberg JM, Venkatachalam MA, Roeser NF, Nissim I. Mitochondrial dysfunction during hypoxia/reoxygenation and its correction by anaerobic metabolism of citric acid cycle intermediates. Proc. Natl. Acad. Sci. U.S.A. (2000) 97:2826-31.
137. Maevsky EI, Peskov AB, Uchitel ML, Pogorelov AG, Saharova NY, Vihlyantseva EF, et al. A succinate-based composition reverses menopausal symptoms without sex hormone replacement therapy. Adv Gerontol (2008) 21(2):298-305.
138. Chen JQ, Yager JD, Russo J. Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications. Biochim Biophys Acta (2005) 1746:1-17. doi:10.1016/j.bbamcr.2005.08.001
139. Toth I, Kiss DS, Goszleth G, Bartha T, Frenyo LV, Naftolin F, et al. Hypothalamic sidedness in mitochondrial metabolism: new perspectives. Reprod Sci (2014) 21:1492-8. doi:10.1177/1933719114530188
140. Mittelman-Smith MA, Williams H, Krajewski-Hall SJ, McMullen NT, Rance NE. Role for kisspeptin/neurokinin B/dynorphin (KNDy) neurons in cutaneous vasodilatation and the estrogen modulation of body temperature. Proc Natl Acad Sci U S A (2012) 109:19846-51. doi:10.1073/pnas.1211517109
141. Wylie-Rosett J. Menopause, micronutrients, and hormone therapy. Am J Clin Nutr (2005) 81(5):1223S-31S.
142. Roa J. Role of GnRH neurons and their neuronal afferents as key integrators between food intake regulatory signals and the control of reproduction. Int J Endocrinol (2013) 2013:518046. doi:10.1155/2013/518046